Skip to main navigation Skip to search Skip to main content

Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCL

  • Yi Jiun Su
  • , Anne Marijn Kramer
  • , Mark P. Hamilton
  • , Neha Agarwal
  • , Hrishikesh K. Srinagesh
  • , John H. Baird
  • , Bita Sahaf
  • , Adam Kuo
  • , Zachary J. Ehlinger
  • , Moksha H. Desai
  • , Skyler P. Rietberg
  • , Ramya Tunuguntla
  • , Shabnum Patel
  • , Harshini Chinnasamy
  • , Nikolaos Gkitsas-Long
  • , Dorota D. Klysz
  • , Annie Kathleen Brown
  • , Sushma Bharadwaj
  • , Saurabh Dahiya
  • , Melody Smith
  • Lori Muffly, Crystal L. Mackall, Zinaida Good, Steven A. Feldman, David B. Miklos, Matthew J. Frank

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCL'. Together they form a unique fingerprint.
Sort by

Keyphrases

Immunology and Microbiology